Product Images Dihydroergotamine Mesylate

Dihydroergotamine mesylate is a chemical compound with the molecular formula Ca3Ha7NsOseCH403S and a molecular weight of 679.80. Further information about its properties or uses is not available from the provided text.*

This appears to be a table or graph that shows the estimated probability of response to Dihydroergotamine Mesylate nasal spray during the four hours following dosing. The estimated probability of response is 0.5%. The data was obtained from studies 3 and 4, which involved 97 patients receiving Dihydroergotamine Mesylate and 100 patients receiving a placebo. The table or graph also includes time intervals from the first dose in hours.*

The text describes a graph, specifically "Figure 3" that shows the estimated probability of patients using additional treatments for migraine over 24 hours following the usage of Dihydroergotamine Mesylate Nasal Spray 2 mg (compared to placebo). The graph includes a sample size (N) of 305 for the Dihydroergotamine Mesylate group and 300 for the Placebo group. The x-axis represents the hours after the first spray, while the y-axis shows the estimated probability of analgesic use.*

This text describes a nasal spray medication containing 4 mg/mL of Dihydroergotamine mesylate, which is an equivalent to 3.43 mg of dihydroergotamine. It is only intended for nasal use and not for injection. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

This is a pharmaceutical product from Amneal Pharmaceuticals LLC in Bridgewater, NJ 08807. It is a nasal spray administration of Dihydroergotamine Mesylate intended for use prior to the onset of a migraine attack. It is important to note that this is not for individual sale or for injection. The product comes with a vial containing 4mg/mL of the medication, and one sprayer. The lot/exp number is labeled on a 1.9"x1.28" non-varnish area. Storage instructions indicate not to refrigerate or freeze and to keep the product below 25°C (77°F).*

This text seems to include medical information about "Dihydroergotamine Mesylate Nasal Spray" which should not be injected and it should only be used for nasal purposes. Each 1 mL contains dinytroergotamine mesylate 4mg, calfeie, anhydrous 0.5mg, destoss, antydous 50mg, cabon Goide as, and purfedvater. The package of this spray contains 8 Diuegranios Mesfae Vols, 8 Diyosmamios Mesfals sl Sy, « dmistaton etuctors, «Package sert. It also includes some instructions on usage, storage, and possible side effects that are detailed in the enclosed package insert.*